Role of Radiation Therapy in Parameningeal Rhabdomyosarcoma

References

• Maurer H M, Beltangady M, Gehan E A, et al. The Intergroup Rhabdomyosarcoma study. I. A final report. Cancer 1988; 61: 209–220
   PubMed Web of Science ®Google Scholar
• Maurer H M, Gehan E A, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993; 71: 1904–1922
   PubMed Web of Science ®Google Scholar
• Tefft M, Fernandez C, Donaldson M, et al. Incidence of menin-geal involvement by rhabdomyosarcoma of the head and neck in children. A report of the Intergroup Rhabdomyosarcoma Study (IRS). Cancer 1978; 42: 253–258
   Google Scholar
• Benk V, Rodary C, Donaldson S S, et al. Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys 1996; 36: 533–540
   PubMed Web of Science ®Google Scholar
• Newton W A, Soule E H, Hamoudi A B, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma studies I and II: clinicopathologic correlation. J Clin Oncol 1988; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Lawrence W, Hays D M, Heyn R, et al. Lymphatic metastases with childhood rhabdomyosarcoma: a report from the lntergroup Rhabdomyosarcoma Study. Cancer 1987; 60: 910–915
   PubMed Web of Science ®Google Scholar
• Chan R C, Sutow W W, Lindberg R D. Parameningeal rhabdomyosarcoma. Radiology 1979; 131: 211–214
   PubMed Web of Science ®Google Scholar
• Berry M P, Jenkin R DT. Parameningeal rhabdomyosarcoma in the young. Cancer 1981; 48: 281–288
   PubMed Web of Science ®Google Scholar
• Gasparini M, Lombardi F, Gianni C, et al. Childhood rhahdomyosarcoma with meningeal extension: results of combined therapy including central nervous system prophylaxis. Am J Clin Oncol 1983; 6: 393–398
   PubMed Web of Science ®Google Scholar
• Gerson J M, Jaffe N, Donaldson M H, et al. Meningeal seeding from rhabdomyosarcoma of the head and neck with base of the skull invasion: recognition of the clinical evolution and suggestions for management. Med Pediatr Oncol 1978; 5: 137–144
   PubMedGoogle Scholar
• Prat J, Gray G F. Massive neuraxial spread of aural rhabdomyosarcoma. Arch Otolaryngol 1977; 103: 301–303
   PubMed Web of Science ®Google Scholar
• Raney R B, Zimmerman R A, Bilaniuk L T, et al. Management of craniofacial sarcoma in childhood assisted by computed tomography. In J Radiat Oncol Biol Phys 1979; 5: 529–534
   PubMed Web of Science ®Google Scholar
• Raney R B, Tefft M, Newton W A, et al. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites: a report from the Intergroup Rhabdomyosarcoma Study. Cancer 1987; 59: 147–155
   PubMed Web of Science ®Google Scholar
• Raney B, Tefft M, Heyn R, et al. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma. Cancer 1992; 69: 1498–1506
   PubMed Web of Science ®Google Scholar
• Waher D, Tarbell N, Fairclough D, et al. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995; 13: 2490–2496
   PubMed Web of Science ®Google Scholar
• Ochs J, Mulhern R, Fairclough D, et al. Comparison of neuropsy-chologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991; 9: 145–151
   PubMed Web of Science ®Google Scholar
• Crist W, Gehan E A, Ragab A H, et al. The third Intergroup Rhahdomyosarcoma Study. J Clin Oncol 1995; 13: 610–630
   PubMed Web of Science ®Google Scholar
• Gasparini M, Lombardi F, Gianni M C, et al. Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma with meningeal extension. J Clin Oncol 1990; 8: 1854–1857
   PubMed Web of Science ®Google Scholar
• Donaldson S S, Asmar L, Breneman J, et al. Hyperfractionated radiation in children with rhdbdomyosarcoma—results of an Intergroup Rhabdomyosarcoma pilot study. Int J Radiat Oncol Biol Phys 1995; 32: 903–911
   PubMed Web of Science ®Google Scholar
• Hall E J. Time, dose and fractionation in radiotherapy. Radiobiology for the Radiologist., 4th ed., E J Hall. J.B. Lippincott, Philadelphia 1994; 211–229
   Google Scholar
• Eifel P, Sampson C, Tucker S. Radiation fractionation sensitivity of epiphysial cartilage in a weanling rat model. Int J Radiat Oncol Biol Phys 1990; 19: 661–664
   PubMed Web of Science ®Google Scholar
• Horiot J C, LeFur R, Nguyen T, et al. Hyperfractionation vs. conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy. Radiother Oncol 1992; 25: 231–241
   Google Scholar
• Mandell L R, Ghavimi F, Exelhy P, et al. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhahdomyosarcoma. Int J Radiat Oncol 1988; 15: 197–203
   PubMed Web of Science ®Google Scholar
• Merchant T E, Ghavimi F, Cahill J. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma. Radiology 1995; 197: 224, (abstract)
   Web of Science ®Google Scholar
• Lanciano R M, Pajak T F, Manrtz K, et al. The influence of treatment time on outconie for squamous call cancer of the uterine cervix treated with radiation: a patterns-of-care study. lnt J Radiat Oncol Biol Phys 1993; 25: 391–397
   PubMed Web of Science ®Google Scholar
• Fyles A, Keane T J, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273–279
   PubMed Web of Science ®Google Scholar
• Barton M B, Keane T J, Gadalla T, et al. The effect of treatment time and treatment interruption on tumor control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137–143
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Johansen L V, Overgaard J, et al. Clinical radiobiol-ogy of squamous cell carcinoma of the oropharynx. Jnt J Radiat Oncol Biol Phys 1991; 20: 1197–1206
   PubMed Web of Science ®Google Scholar
• Habrand J L, Sponner D, Barrett A, et al. Radiation therapy (RT) in the initial management of localized malignant mesenchymal tumors (MMT). Update of the SIOP MMT 89 Study [abstract]. Med Pediatr Oncol 1996; 27: 236
   Google Scholar
• Gandola L, Lombardi F, Cefalo G, et al. Local control and toxicity of hyperfractionated accelerated radiotherapy (3 fraction/day) for IRS-Group III rhabdomyosarcoma (RMSA) [abstract]. Med Pediatr Oncol 1997; 29: 341
   Google Scholar
• Merchant T E. Delayed-accelerated hyperfractionated radiation therapy for advanced-stage or high-risk rhabdomyosarcoma. Med Pediatr Oncol 1997; 29: 45–50
   PubMedGoogle Scholar
• Fu K K, Clery M, Ang K K, et al. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88–09. Int J Radiat Oncol Biol Phys 1995; 32: 589–597
   PubMed Web of Science ®Google Scholar
• Raney R B, Asmar L, Vassilopoulou-Sellin R, et al. Late sequelae in 162 patients with non-orbital soft tissue sarcoma of the head and neck: report from Intergroup Rhabdomyosarcoma Studies (IRS) II and III [abstract]. Proc Am Soc Clin Oncol 1995; 14: 454
   Google Scholar
• Uyttebroeck A, Froncois I, Menten J, et al. Growth hormone deficiency after treatment for rhabdomyosarcoma of the maxillo-facial region [abstract]. Med Pediatr Oncol 1997; 29: 484
   Google Scholar
• Fromm M, Littman P, Raney R B, et al. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck: experience at a single institution with a review of the literature. Cancer 1986; 57: 2070–2076
   PubMed Web of Science ®Google Scholar
• Heyn R, Haeberlen V, Newton W A, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 1993; 11: 262–270
   PubMed Web of Science ®Google Scholar
• Michalski J M, Sur R K, Harms W B, et al. Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyo-sarcomas. Int J Radiat Oncol Biol Phys 1995; 33: 985–991
   PubMed Web of Science ®Google Scholar
• Flamant F, Rodary C, Vante P A, et al. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results. Radiother Oncol 1985; 3: 227–236
   PubMed Web of Science ®Google Scholar
• Blatt J, Snyderman C, Wollman M, et al. Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood. Med Pediatr Oncol 1997; 29: 294–298
   Google Scholar
• Posniak J C, Polley J W, Zuker R M, et al. Chemotherapy and surgical resection combined with immediate reconstruction in a 1 year old child with rhabdomyosarcoma of the maxilla. Plast Reconstr Surg 1992; 89: 320–325
   PubMed Web of Science ®Google Scholar